质谱分析揭示微小病变与局灶节段性肾小球硬化中足细胞蛋白丢失
本研究采用激光显微切割联合质谱(LMD/MS)分析成人肾活检组织,比较微小病变(MCD)、原发性局灶节段性肾小球硬化(pFSGS)、继发性FSGS(sFSGS)和遗传性FSGS(gFSGS)中足细胞蛋白表达,并以时间零点移植肾(T0)和膜性肾病(MN)作对照。结果显示MCD、pFSGS、sFSGS和gFSGS中六种足细胞蛋白均显著丢失,而MN无显著丢失,提示共同终末损伤通路。
要点
- MCD与各种FSGS均存在足细胞蛋白显著丢失,支持疾病连续谱假说。
- MN虽有蛋白尿但足细胞蛋白无显著丢失,提示损伤机制不同。
- LMD/MS可定量评估肾活检足细胞蛋白相对丰度。
核心结论
- MCD、pFSGS、sFSGS和gFSGS中足细胞蛋白显著且程度相当地丢失,涉及裂孔膜和肌动蛋白细胞骨架,提示共同终末通路。
研究设计与样本
- 观察性质谱研究,采用激光显微切割联合质谱(LMD/MS)分析成人肾活检组织,样本包括MCD(n=6)、pFSGS(n=7)、sFSGS(n=10)、gFSGS(n=6),对照为T0(n=6)、IgAN(n=5)和MN(n=8)。
主要发现
- T0和MN对照中NPHS1、NPHS2、CD2AP、ACTN2、INF2和DAG1呈现中等基线总谱。
- MCD、pFSGS、sFSGS和gFSGS中全部6种足细胞蛋白显著丢失,而MN病例无显著丢失。
- 免疫荧光染色证实MCD、pFSGS、sFSGS和gFSGS中NPHS1和NPHS2丢失,T0或MN中无丢失。
临床怎么用
- 提示MCD与FSGS可能为同一疾病连续谱,足细胞蛋白丢失可作为共同损伤标志。
- MN与FSGS蛋白尿机制不同,足细胞蛋白表达正常,不支持共同终末通路。
局限性
- 观察性研究样本量小,各组n=5-10,需更大样本验证。
- 仅评估特定足细胞蛋白,未全面覆盖所有足细胞分子。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: The relation between minimal change disease (MCD) and primary focal segmental glomerulosclerosis (FSGS) (pFSGS) remains debatable, and the recent discovery of antinephrin and antislit antibodies, supports the hypothesis of a continuum disease. However, the overall expression of podocyte proteins in these disease states is not known. METHODS: In this observational proteomic study, we used laser microdissection and mass spectrometry (LMD/MS) to determine the proteomic profile of podocyte proteins in kidney biopsies of adult patients with MCD (n = 6), pFSGS (n = 7), secondary FSGS (sFSGS) (n = 10), and genetic FSGS (gFSGS) (n = 6). Time-zero kidney transplant (T0) (n = 6), IgA nephropathy (IgAN) (n = 5) and membranous nephropathy (MN) (n = 8) served as nonproteinuric and proteinuric controls, respectively. MS results were expressed as total spectrum representing the relative abundance of the specific protein. In addition, immunofluorescence (IF) staining assessing nephrin (NPHS1) and podocin (NPHS2) were performed. RESULTS: LMD/MS show moderate baseline total spectrum of podocyte proteins, NPHS1, NPHS2, CD2-associated protein, alpha-actinin-2, inverted formin-2 (INF2), and dystroglycan 1 (DAG1) in T0 and MN controls. In contrast, there was a significant loss of all 6 podocyte proteins in MCD, pFSGS, sFSGS, and gFSGS but not in MN cases. IF staining confirmed podocyte loss of NPHS1 and NPHS2 in MCD, pFSGS, sFSGS, and gFSGS but not in T0 or MN. CONCLUSION: LMD/MS and IF staining show significant and comparable loss of podocyte proteins involving the slit diaphragm and actin cytoskeleton in MCD, pFSGS, sFSGS, and gFSGS suggesting a common final pathway of podocyte injury. Surprisingly, despite similar degrees of proteinuria, MN was not associated with significant loss of podocyte proteins.
引用
- Fervenza FC, Vargas-Brochero MJ, Debiec H, et al. Mass Spectrometry of Minimal Change Disease and Focal Segmental Glomerulosclerosis. Kidney Int Rep. 2025. PMID: 41426026. doi:10.1016/j.ekir.2025.09.043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。